# Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis

> **NCT05706870** · PHASE2 · COMPLETED · sponsor: **GEN İlaç ve Sağlık Ürünleri A.Ş.** · enrollment: 190 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** GN-037
- **DRUG:** Clobetasol 17-propionate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05706870
- **Lead sponsor:** GEN İlaç ve Sağlık Ürünleri A.Ş.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-07
- **Primary completion:** 2024-01-04
- **Final completion:** 2024-03-03
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05706870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05706870, "Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05706870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*